The role of hydroxychloroquine in COVID-19: Where do we stand?

被引：0

作者：

Anjana, Ranjit Mohan ^{[1
,2
]}

Sastry, Nadiminty Ganapathi ^{[1
]}

Ramuu, Muthu ^{[1
]}

Gupta, Prasanna Kumar ^{[1
]}

Shalini, Jaggi ^{[1
]}

Srivastava, Brijendra Kumar ^{[1
]}

Kocherlakota, Chaithanya Murthy ^{[1
]}

Nandan, Tata Sameer ^{[1
]}

Praveen, Gangadhara ^{[1
]}

Nair, Jyotish ^{[1
]}

Philips, Routray ^{[1
]}

Mohan, Viswanathan ^{[1
,2
]}

Unnikrishnan, Ranjit ^{[1
,2
]}

机构：

[1] Dr Mohans Diabet Special Ctr, Dept Diabetol, Chennai, Tamil Nadu, India

[2] Madras Diabet Res Fdn, Dept Diabetol, Chennai, Tamil Nadu, India

来源：

JOURNAL OF DIABETOLOGY | 2020年 / 11卷 / 02期

关键词：

Coronavirus disease 2019; hydroxychloroquine; treatment; CHLOROQUINE;

D O I：

10.4103/JOD.JOD_33_20

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Hydroxychloroquine (HCQ) is a drug, which has long been used in the treatment of malaria, rheumatoid arthritis, systemic lupus erythematosus, and Sjogren's syndrome. Recently with the COVID-19 pandemic hitting the world, there have been studies suggesting that hydroxychloroquine may be useful both in the prevention and the treatment of COVID-19, although the evidence so far has been conflicting. This article reviews the available evidence for the use of hydroxychloroquine in COVID-19 and also mentions some of the ongoing trials in this field.

引用

页码：65 / 70

页数：6

共 50 条

[1] Myocarditis and COVID-19: Where Do We Stand?
Jakstaite, Aiste Monika
Papathanasiou, Maria
Luedike, Peter
[J]. AKTUELLE KARDIOLOGIE, 2021, 10 (01) : 27 - 31
[2] COVID-19 and AKI: Where Do We Stand?
Palevsky, Paul M.
[J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (05): : 1029 - 1032
[3] COVID-19 vaccines: Where do we stand?
Tulay, Pinar
Ergoren, Mahmut Cerkez
Dundar, Munis
[J]. EUROBIOTECH JOURNAL, 2021, 5 (01): : 13 - 16
[4] COVID-19 in Children: Where do we Stand?
Nikolopoulou, Georgia B.
Maltezou, Helena C.
[J]. ARCHIVES OF MEDICAL RESEARCH, 2022, 53 (01) : 1 - 8
[5] Chloroquine and COVID-19, where do we stand?
Lecuit, M.
[J]. MEDECINE ET MALADIES INFECTIEUSES, 2020, 50 (03): : 229 - 230
[6] Vaccines for COVID-19: Where do we stand in 2021?
Sharma, Ketaki
Koirala, Archana
Nicolopoulos, Katrina
Chiu, Clayton
Wood, Nicholas
Britton, Philip N.
[J]. PAEDIATRIC RESPIRATORY REVIEWS, 2021, 39 : 22 - 31
[7] Covid-19 and perioperative mortality; where do we stand?
Shakiba, Behnam
Irani, Shirin
[J]. ECLINICALMEDICINE, 2020, 22
[8] COVID-19 Vaccine in Children: Where Do We Stand?
Kumar, Jogender
Meena, Jitendra
[J]. INDIAN PEDIATRICS, 2021, 58 (02) : 194 - 195
[9] COVID-19 and liver injury: where do we stand?
Papadopoulos, Nikolaos
Vasileiadi, Sofia
Deutsch, Melanie
[J]. ANNALS OF GASTROENTEROLOGY, 2020, 33 (05): : 459 - 464
[10] Fluvoxamine for outpatients with COVID-19: where do we stand?
Berwanger, Otavio
[J]. LANCET GLOBAL HEALTH, 2022, 10 (01): : E2 - E3

← 1 2 3 4 5 →